NFKB1 and atopic eczema: A recent study has shown that, in animal models of atopic dermatitis, atopic dermatitis-like symptoms were further improved by inhibiting HMGB1 expression in mast cells, preventing NF-κB nuclear translocation, and reducing the release of cytokines such as TNF-α and IL-1β [21].